1
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Condition(s):Bladder CancerLast Updated:November 21, 2019Completed
Bladder Cancer: 1580 Clinical Trials, Page 1 of 158
Hide Studies Not Open or Pending
2
Metadherin mRNA Expression in Bladder Cancer
Condition(s):Bladder CancerLast Updated:September 29, 2020Not yet recruiting
3
Diagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.
Condition(s):Non-Invasive Bladder Urothelial Carcinoma; Non-Invasive Bladder Papillary Urothelial Carcinoma, Low Grade; Non-Invasive Bladder Papillary Urothelial Carcinoma, High GradeLast Updated:February 9, 2021Completed
4
Biomarker Identification for Bladder Cancer Patients
Condition(s):Bladder CancerLast Updated:March 15, 2021Active, not recruiting
5
UroX Biomarker Bladder Cancer Study
Condition(s):Bladder CancerLast Updated:June 4, 2019Recruiting
6
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
Condition(s):Non-muscle Invasive Bladder Cancer; Urinary BiomarkerLast Updated:February 21, 2020Recruiting
7
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
Condition(s):Bladder Cancer; Bladder Neoplasm; Bladder TumorLast Updated:September 9, 2020Recruiting
8
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)
Condition(s):Non-muscle-invasive Bladder CancerLast Updated:February 7, 2020Recruiting
9
MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
Condition(s):Bladder CancerLast Updated:June 17, 2020Completed
10
Prospective Bladder Cancer Infrastructure (ProBCI)
Condition(s):Bladder CancerLast Updated:March 11, 2021Recruiting